Midi Health Review: No Membership Fee Does Not Mean One Simple Contract

Midi Health’s promise of no membership fees answers one question about enrollment, but not the whole financial agreement. A patient may still be paying for visits, medication, and other services under different arrangements. Certain products can also carry recurring charges. For someone considering its GLP-1 program, the useful question is not simply whether joining costs money: it is what gets purchased, who becomes responsible for delivering it, and which charges continue without another decision.

Public documentation consulted October 19, 2026, describes a virtual women’s health business offering weight-management evaluation, follow-up, and prescriptions when clinically appropriate. This review examines those documented arrangements rather than treating Midi as a single-price medication subscription. Important uncertainties remain, including conflicting Medicare statements and different descriptions of geographic availability. The consulted terms also contain an omitted central section, so they cannot support a complete account of every contractual obligation.

At a glance

Membership versus purchases: Midi advertises no membership fees, but visits and medication are charged separately; certain products may have automatically renewing subscriptions.
Sources: [9] [5] [12]
Self-pay appointments: The listed self-pay price is $250 for an approximately 30-minute first visit and $150 for a 15-minute returning visit.
Sources: [6]
Compounded medication starting price: Compounded GLP-1 and GLP-1/GIP medication starts at $164 per four-week supply, depending on medication, format, and dose, with shipping and supplies included; visits cost extra.
Sources: [5]
Separate care organizations: Midi’s terms identify it as the platform operator, not the healthcare provider, and name four medical groups through which care may be provided.
Sources: [12]
Cancellation boundary: For applicable subscriptions, cancellation must precede the deadline in the subscription terms to avoid the next charge; partially used periods ordinarily are not refunded.
Sources: [12]

Start with the parties, not the clinic label

Midi presents itself as a virtual healthcare clinic for women and says its clinicians are board-certified and trained in women’s health. Those are provider statements, not independently verified credentials in this review. Its legal terms make a separate distinction: Midi Health, Inc. and its subsidiaries operate the platform, while using the service does not itself create a healthcare provider–patient relationship with Midi. That distinction matters when identifying who is responsible for a medical decision.

The terms identify Integrative Women’s Care PC, IWC Medical Group, P.A., IWC Medical Group KS, P.A., and Robert G. Aptekar, M.D., P.C. as medical groups accessible through the platform. They employ or contract with physicians, nurses, and other health professionals. A clinician should therefore not automatically be described as a physician, and the platform’s customer-support role should not be confused with the treating professional’s responsibilities.

Before accepting enrollment terms, ask which medical group will provide your care and where clinical questions should go. Separately identify the organization collecting each payment and the pharmacy filling any prescription. Our guide to mapping platform, clinician, and pharmacy responsibilities explains why those distinctions are useful. Midi’s documentation supplies several names, but a patient still needs to connect those organizations to the particular appointment and product being purchased.

Sources: [11] [12]

Enrollment buys an evaluation, not a guaranteed prescription

Midi’s intake questionnaire asks about health and weight history, current medications, past treatments, risk factors, and goals. The first virtual visit runs about 30 minutes and covers history, symptoms, previous treatment, and a proposed care plan. Its terms require a completed consultation, a clinician’s determination that a prescription is appropriate, and a valid prescription before a prescription product can be obtained. Booking an appointment is not a promise of medication.

The advertised care plan may include GLP-1 medication, laboratory orders, and guidance. Midi describes targeted tests such as blood sugar or cholesterol and 15-minute follow-up visits for reviewing progress and making adjustments. It also says clinicians help manage treatment side effects. These are documented service descriptions, but they do not establish a uniform testing schedule, a guaranteed number of follow-ups, or a specific response time between appointments.

General access requires being at least 18, or the local age of majority if higher, and being located in a state the service serves. The consulted documentation does not establish complete medication-specific eligibility criteria or uniform laboratory requirements. Before paying, distinguish the visit being purchased from possible later services: ask what happens financially if the clinician recommends a different approach or does not prescribe. A specific refund promise for that situation was not established.

Sources: [5] [12] [8]

Separate the visit bill from the medication order

The published self-pay appointment prices are concrete: $250 for the initial 30-minute visit and $150 for a 15-minute returning visit. Midi advertises no membership fees and says patients pay for care and medication. That does not make either component free, and it does not establish how frequently returning appointments will be necessary. There is no documented all-inclusive treatment price combining visits, medication, and laboratory work for a defined period.

Compounded GLP-1 and GLP-1/GIP medication starts at $164 per four-week supply, depending on medication, format, and dose. Shipping and supplies are included in that quoted medication price; the consultation is not. Four weeks is not a calendar month. Midi separately advertises programs it calls microdosing, when clinically appropriate, with weekly doses starting at $34 for eligible patients. That is a conditional medication offer, not an all-in weekly care price.

Brand-name prescriptions go to the patient’s chosen pharmacy, and their cost depends on the drug and insurance. Midi says HSA or FSA funds can pay for its visits and services, but that statement does not resolve every expense associated with treatment. Request an itemized estimate identifying the exact product, route, quantity, payment interval, and separate fees. Our written GLP-1 quote checklist can help organize that request without converting starting prices into a promised total.

Documented charges and the boundaries of each quote
Purchase	Published amount	Important condition
Initial self-pay visit	$250	Approximately 30 minutes; medication separate
Returning self-pay visit	$150	15 minutes; visit frequency not established
Compounded GLP-1 or GLP-1/GIP	Starts at $164 per four-week supply	Varies by medication, format, and dose; shipping and supplies included
Advertised microdosing offer	Weekly doses start at $34	Eligible patients only, when clinically appropriate; not total care cost
Brand-name GLP-1	No single published price	Chosen pharmacy; cost depends on drug and insurance

Sources: [6] [9] [5]

Insurance acceptance has important exceptions

Midi says it is in-network with most major insurers nationwide, but coverage depends on the individual plan. Deductibles, coinsurance, and copays may remain payable. During registration, patients are asked for a photograph of their insurance card; the system reports whether they are in-network or out-of-network. An out-of-network patient can choose a self-pay appointment. That screening process is useful, but it is not a blanket assurance that every service or drug will be covered.

The Medicare language needs particular care. Midi’s pricing page says Medicare is out-of-network, welcomes beneficiaries as self-pay patients, and says they cannot submit claims related to Midi visits, medications, or associated services. A separate article, updated in December 2024, says Midi cannot treat Medicare, Medicaid, or Medi-Cal patients even on a self-pay basis. The two statements conflict for Medicare, and the consulted documentation does not conclusively resolve which policy applies.

For Medicaid and Medi-Cal, the pricing page also says patients are not currently accepted. Medicare beneficiaries should obtain direct confirmation of eligibility and applicable billing restrictions before reserving rather than assuming either passage settles the question. More generally, appointment coverage and medication coverage are separate questions. NIDDK notes that some plans cover weight-management medicines and others do not; the relevant plan must confirm the patient’s particular benefits.

Sources: [6] [4] [2]

Identify the formulation and pharmacy before authorizing payment

Midi documents both brand-name and compounded prescribing. Its compounded GLP-1 page describes self-injection and oral drops, with the drops placed under the tongue. Those drops should not be confused with swallowed tablets. The consulted documentation does not unambiguously identify the active ingredient in every preparation labeled GLP-1 or GLP-1/GIP. Educational references to particular drugs are not enough to assign those ingredients to every marketed formula or establish equivalent evidence across routes.

The terms name Precision Compounding Pharmacy as a prescription-fulfillment provider. Midi separately describes its partner compounding pharmacies as licensed and “503A-accredited”; this review has not independently verified those claims. The terms also allow requests for an outside pharmacy for applicable prescriptions. In that arrangement, the service sends the prescription, while the patient pays the pharmacy directly and arranges pickup or otherwise obtains the medication. That is not an assurance that every formula is available through every pharmacy.

Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness, and quality. FDA recommends them when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence or validate a provider. For enrollment purposes, get the exact formulation, route, dispensing pharmacy, and reason for the proposed preparation clarified before treating a medication quote as sufficiently specific.

Sources: [12] [9] [8] [5] [1]

No membership fee can coexist with automatic renewal

Midi’s terms say certain products and services, including supplements and certain prescription products called CustomRX, may be purchased on an automatically renewing subscription basis. The payment method is then charged repeatedly until cancellation. This is not evidence that every Midi GLP-1 prescription uses a subscription. It does mean that the absence of a membership charge should not be interpreted as the absence of recurring product charges. The checkout terms for the actual order matter.

Timing deserves close attention. The terms say the first renewal may be charged early to prevent a treatment interruption. Subsequent shipments may be charged and shipped up to two days early for holidays or operational reasons. The first-renewal provision does not specify the same two-day limit. A patient therefore needs the actual charge schedule and cancellation deadline rather than assuming that the nominal shipment date is the last opportunity to stop a renewal.

CustomRx subscription orders also require an active, refill-eligible prescription, an eligible product, pharmacy ability to dispense, and legal availability in the patient’s state before billing or shipping. Those conditions make renewal dependent on more than payment authorization. Ask which subscription terms apply, what notice is provided, and how clinical reassessment interacts with refills. Our guide to billing intervals and ongoing commitments distinguishes a recurring price from a minimum commitment; neither should be inferred from supply duration alone.

Sources: [9] [12]

Cancellation stops future charges only within the applicable rules

For applicable subscriptions, Midi allows cancellation through an account link or button, by emailing support@joinmidi.com, or by calling 1-888-731-8994. To avoid the next charge, cancellation must occur before the deadline stated in the subscription terms. The consulted text does not supply one universal advance-notice period for every product. Read the order-specific deadline alongside the early-charge provisions, and request confirmation that cancellation has been recorded for the intended subscription.

The refund boundary is separate. Midi says it does not ordinarily refund partially used subscription periods, although it may make discretionary exceptions and recognizes applicable legal requirements. Being able to cancel at any time does not promise reimbursement for an already paid period or reversal of a processed order. Our guide to cancellation notice and order status explains why the request date, upcoming charge, and fulfillment stage should be checked separately.

Appointment cancellation is another unresolved category: the consulted documentation does not establish a specific late-cancellation or no-show policy. Do not assume the subscription policy governs an appointment, or vice versa. Product pages can create additional ambiguity. The Daily GLP-1 Support supplement page advertises both a 20% subscription discount and a 10% recurring discount. It describes monthly supply, free standard shipping, and pause or cancellation options, but the effective discount needs confirmation.

Sources: [12] [3]

Confirm availability, delivery, and the right support channel

Midi’s general weight-program page says care is available in all 50 states, but a GLP-1-specific article says the offering is not available in all 50 states. These statements should not be collapsed into nationwide access to every formulation. No formulation-by-state list was established in the consulted documentation. Confirm availability for the exact product and your location before payment, especially when choosing between a brand-name prescription, compounded injection, and sublingual drops.

The store terms require a physical U.S. address for product purchases. The documentation does not establish guaranteed clinical-review, dispatch, or arrival timelines, or specific cold-chain conditions. Early dispatch is not early delivery. The terms also warn that not all prescriptions filled by partner pharmacies use child-resistant packaging. Separately, FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy to resolve the concern.

Published accessibility and order-support hours are Monday through Friday, 9 a.m. to 5 p.m. Eastern, through store@joinmidi.com or 1-888-731-8994; these are not a promise of continuous clinical coverage. A Midi article says ondansetron tablets are supplied with personalized GLP-1 prescriptions, but does not establish their price or universal inclusion. Its Daily GLP-1 Support product is described as a nutritional supplement, not a weight-loss product itself or a means of changing GLP-1 efficacy.

Sources: [5] [7] [12] [10] [3] [1]

Questions & answers

Does Midi’s no-membership policy mean there are no recurring charges?

No. Midi advertises no membership fees, while its terms allow subscriptions for certain supplements and prescription products called CustomRX. That does not establish that every GLP-1 order renews automatically. Before checkout, ask whether your particular purchase is recurring, when it will be charged, and which cancellation deadline applies.

Sources: [9] [12]

Is the $164 price the total cost of starting Midi?

No. It is a starting price for a four-week supply of compounded GLP-1 or GLP-1/GIP medication, varying by medication, format, and dose, with shipping and supplies included. Visits are separate. The initial self-pay visit is listed at $250, and the documentation does not establish a complete treatment total including laboratory costs.

Sources: [5] [6]

Can Medicare beneficiaries book a self-pay appointment?

The documentation conflicts. The pricing page welcomes Medicare beneficiaries as self-pay patients, while prohibiting related claims. A separate article says Medicare patients cannot be treated even as self-pay patients. Obtain confirmation before booking and ask which payment restrictions apply. The pricing page also says Midi does not currently accept Medicaid or Medi-Cal patients.

Sources: [6] [4]

Can I use a pharmacy other than Midi’s named partner?

Midi advertises brand-name prescriptions sent to the pharmacy of your choice. Its terms also describe outside-pharmacy fulfillment for applicable prescriptions: the service sends the prescription, and you pay that pharmacy directly and arrange to obtain the product. Confirm that the exact prescribed formulation can be filled there rather than assuming every compounded product is transferable.

Sources: [5] [12]

How do I cancel a Midi product subscription?

The terms offer an online account cancellation mechanism, support@joinmidi.com, and 1-888-731-8994. Cancel before the deadline in your subscription terms to avoid the next charge, accounting for possible early billing. Cancellation does not ordinarily refund a partially used subscription period. Ask separately about any appointment cancellation because a specific late-cancellation or no-show policy was not established.

Sources: [12]

Does Midi offer the same GLP-1 options in every state?

That is not confirmed. The general program page advertises all-50-state availability, but a GLP-1-specific article says availability is not nationwide. Ask about your exact medication, route, and state before paying. The terms also condition CustomRx subscription fulfillment on prescription validity, refill eligibility, product eligibility, pharmacy availability, and legal availability in the state.

Sources: [5] [7] [12]

Our assessment

Midi documents a recognizable care pathway: intake, a substantial first visit, clinician-directed prescribing, and shorter follow-ups, with published self-pay appointment prices and a conditional compounded-medication starting price. Its no-membership model may appeal to patients who want care billed separately from medication. The contractual qualification is that some product purchases can still renew automatically, charge early, and carry limited refund rights. Before enrollment, the most useful confirmations are the treating medical group, exact medication and pharmacy, itemized charges, applicable renewal deadline, and appointment cancellation policy. Medicare eligibility and formulation-specific state availability deserve explicit answers because the public documentation differs. The available material supports evaluating Midi as a documented GLP-1 care option, but not assuming one uniform national product, one comprehensive price, guaranteed prescribing, or provider-specific clinical results.

Visit Midi Health’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Midi Health Review: No Membership Fee Does Not Mean One Simple Contract

At a glance

01Start with the parties, not the clinic label

02Enrollment buys an evaluation, not a guaranteed prescription

03Separate the visit bill from the medication order

04Insurance acceptance has important exceptions

05Identify the formulation and pharmacy before authorizing payment

06No membership fee can coexist with automatic renewal

07Cancellation stops future charges only within the applicable rules

08Confirm availability, delivery, and the right support channel